An alliance of drugmakers and research organizations is participating in the Project Data Sphere initiative to collect and make available anonymized patient-level data from late-stage comparative oncology studies. The platform is funded by the CEO Roundtable on Cancer's Life Sciences Consortium, and participants include Memorial Sloan Kettering Cancer Center, AstraZeneca, Bayer, Celgene, Johnson & Johnson, Pfizer and Sanofi. "The real power of this is going to come from getting very large numbers of datasets and combining that with the power of the crowd," said Charles Hugh-Jones, vice president of medical affairs, North America, at Sanofi Oncology.
Drugmakers collaborate to discover cancer drugs
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore